Arkolith/Insider Trading/ARTV/Form 4

Aslan Fred

President and CEO, DirectorArtiva Biotherapeutics, Inc. (ARTV) · full profile →Form 4 · filed Nov 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$22K
Net Open-Market Flow
-$22K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 17, 2025Sell(S)6K$3.38$22K344K
Nov 15, 2025Tax withholding(F)6K$3.25$21K350K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-285004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML